Minimize Multiple Anticholinergics in Older Patients
April 2025
You’ll see renewed focus on limiting anticholinergic meds in older adults...due to a new Star Ratings quality measure for Medicare plans.
We know anticholinergics are on the Beers Criteria of potentially harmful drugs in patients 65 years and older...due to the risk of cognitive impairment, falls, etc. They’re also associated with dementia.
Medicare plans will be evaluated on use of multiple anticholinergic meds in older adults in the Star Ratings program for 2027. But this matters NOW...since ratings are based on data from 2 years prior.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote